Groupe la Francaise’s Charles River Laboratories CRL Stock Holding History

Groupe la Francaise’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$107K	Hold	494	–	–	﹤0.01%	427
2026 Q1	$78.6K	Sell	494 -67	-12%	-$12.4K	﹤0.01%	395
2025 Q4	$112K	Sell	561 -15	-3%	-$2.72K	﹤0.01%	387
2025 Q3	$85.5K	Hold	576	–	–	﹤0.01%	462
2025 Q2	$86.6K	Sell	576 -14	-2%	-$1.87K	﹤0.01%	397
2025 Q1	$98.7K	Buy	590 +182	+45%	+$30.5K	﹤0.01%	388
2024 Q4	$75.2K	Buy	+408	New	+$78.6K	﹤0.01%	306

Other funds holding CRL

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Groupe la Francaise's CRL Position: Q2 2026 in Review

Groupe la Francaise held its Charles River Laboratories (CRL) position steady in Q2 2026 at 494 shares worth $107K. The position accounts for ﹤0.01% of the portfolio, ranked #427.

Groupe la Francaise first reported a position in CRL in Q4 2024 and has held it in 7 quarters since. The position peaked at $112K in Q4 2025. 568 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

Groupe la Francaise held 494 shares of Charles River Laboratories worth $107K as of Q2 2026.
Groupe la Francaise left its Charles River Laboratories share count unchanged in Q2 2026.
Charles River Laboratories made up ﹤0.01% of Groupe la Francaise's portfolio in Q2 2026, its #427 holding.
Groupe la Francaise first reported a position in Charles River Laboratories in Q4 2024 and has held it in 7 quarters since.
Groupe la Francaise's Charles River Laboratories position peaked at $112K in Q4 2025.
568 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Groupe la Francaise's 13F filing for Q2 2026, filed 25 Aug 2026.